to evaluate the safety, immunogenicity, and potential efficacy of a candidate vaccine to prevent COVID-19 infection and/or disease in the South African population
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-021500
Grant search
Key facts
Disease
COVID-19Start & end year
2020Known Financial Commitments (USD)
$15,000,000Funder
Gates FoundationResearch Location
United States of AmericaLead Research Institution
Novavax, Inc.Research Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Clinical trial (unspecified trial phase)Special Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
N/A